Delivery Order SPE2DB24D8001-SPE2DB25FKZES

Award Date 2/11/25
Potential Completion Date 2/12/25
Potential Value $1.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of Trulicity 0.75 mg/0.5 ml pens. The contract has a firm fixed price of $2,566.28 and a performance period ending on January 6, 2025. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00, which allows Dakota Drug, Inc. to provide a range of pharmaceutical products, medical supplies, and healthcare...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical division to Dakota Drug, Inc., a self-certified small disadvantaged business, for the supply of Trulicity 3 mg/0.5 ml pens. The contract has a ceiling value of $1,633.25 and a performance period ending on May 1, 2023. This delivery order is part of Dakota Drug, Inc.'s larger Indefinite Delivery Contract (IDC) with the DLA, identified as SPE2DB24D8001, valued at $999,999,999.00. This...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $1,896.78, is for the delivery of Trulicity 1.5 mg/0.5 ml pens to support medical operations of the U.S. Armed Forces. The contract falls under the DLA Troop Support Medical's ECAT Generation V Program, which procures commercial medical equipment, accessories, consumables, and medical simulation equipment...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical division to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of Trulicity 0.75 mg/0.5 ml pens, a prescription medication used to treat diabetes. The contract has a total ceiling value of $3,656.14 and a performance period extending through May 5, 2023. Dakota Drug, Inc. is a key supplier to the DLA, holding a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML pharmaceutical products. The contract has a ceiling value of $1,273.30 and a performance period extending through January 31, 2025. The award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical's ECAT Generation V Program, which allows Dakota Drug, Inc. to...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business, for the supply of Trulicity 0.75 mg/0.5 ml pens. The contract has a potential value of $1,312.08 and a completion date of February 28, 2024. Dakota Drug, Inc. has extensive experience as a prime contractor to the federal government, particularly the Department of Defense and DLA, supplying a wide range of pharmaceutical...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit Subchapter S corporation. The contract, valued at $2,882.20, is for the delivery of Trulicity 1.5 mg/0.5 ml pens. This order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical's ECAT Generation V Program, valued at $999,999,999.00, which allows Dakota Drug, Inc. to provide a...
This contract award was made by the Defense Logistics Agency (DLA), a defense agency, to Dakota Drug, Inc., a self-certified small disadvantaged business. The $1,505.02 Firm Fixed Price Delivery Order contract is for the supply of Trulicity 3 mg/0.5 ml pen 0.5 ml, a prescription pharmaceutical product. The contract has an ultimate completion date of October 23, 2024. This award is part of Dakota Drug, Inc.'s larger Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, which...
This federal contract award was made by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of Trulicity 0.75 mg/0.5 ml pens. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $4,174.51 and a completion date of September 26, 2023. Dakota Drug, Inc. is a key supplier for the DLA's Troop Support Medical division, providing a wide range of pharmaceutical products, medical supplies, and healthcare...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $5,960.21, is for the delivery of Trulicity 1.5 mg/0.5 mL pens to support military medical operations. Dakota Drug, Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical's ECAT Generation V Program, valued at $999,999,999.00, which allows the company to provide a wide range...
  • SPE2DB24D8001
    Indefinite Delivery Contract
  • SPE2DB24D8001-SPE2DB25FKZES
    Delivery Order

This is a federal contract award issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of Trulicity 0.75 mg/0.5 ml pens. The contract, identified as SPE2DB24D8001|SPE2DB25FKZES, is a Firm Fixed Price Delivery Order with a ceiling value of $1,258.16 and a completion date of February 12, 2025. The contract is not set aside and is part of the DLA Troop Support Medical's ECAT Generation V Program, which allows Dakota Drug, Inc. to provide a comprehensive range of pharmaceutical products, medical supplies, and healthcare equipment to support U.S. Armed Forces medical operations. As a key supplier in the federal marketplace, Dakota Drug, Inc. has a significant single-award Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, with a performance period extending through December 31, 2025.

Generated 5/13/25, 10:34 AM